200 likes | 561 Views
Creating a Benign Hematology Curriculum. Susan Claster MD Division of Hematology Oncology UCI Medical Center. Thank you. What is Benign Hematology?. Clotting/thrombophilia Bleeding disorders Hemoglobinopathies Non malignant disorders of RBCs,WBCs and plts Autoimmune disorders. Case.
E N D
Creating a Benign Hematology Curriculum Susan Claster MD Division of Hematology Oncology UCI Medical Center
What is Benign Hematology? • Clotting/thrombophilia • Bleeding disorders • Hemoglobinopathies • Non malignant disorders of RBCs,WBCs and plts • Autoimmune disorders
Case • 25 y/o female • Jaundiced since childhood • Hgb 9, MCV 65, WBC 13, plts normal • Bili 5, mostly indirect • s/p chole as a teenager • Had been seen by several community H/O MDs who were unable to make a dx • Failed iron,vitamins • FHx positive
Diagnosis • Smear: thal intermedia • Globin gene mapping confirms heterozygous dominant beta thal with severe mutation • Started on HU low dose • Doing well
Workforce Issues • Most HemeOncpractioners are oriented towards liquid or solid malignancies • The average age of BH according to a recent survey by ASH was between 50-60 y/o • Example: only 4 adult hematologists in California and 15 in the US who specialize in hemoglobinopathies
Clinical focus of trainee graduates who pursue private practice or academic careers
Workforce Issues- NIH 2012 • Career opportunities are limited to academic positions • Current NIH funding issues take physician-scientists out of clinic- lack of exposure to these individuals for current trainees • Concept of a “systems hematologist”- inpatient specialist • “Enriching the Hematology Research Workforce through Short-term Educational Experiences in Emerging Science Research Education Program Grant (R25) “
Background UCI • Prior structure: one fellow covering both Heme and Onc consults- allowed no time for teaching • Clinical Lab rotation for fellows started 7/12 • Previously Team O attending saw all Heme consults • Monthly heme case conference started 3/13 but transitioned to weekly meeting starting early 2014 which allowed us to review data in real time
Goals of Rotation • Increase trainee’s fund of knowledge regarding benign hematology • Allow for trainee to have more time for reading, learning by splitting Heme and Onc consult servies • Engage trainees to become interested in this field
Collaborators • KanwarKahlon- HemeOnc • DeepaJeyakumar- HemeOnc • Minh ha Tran- Transfusion Medicine • Irina Maramica- Transfusion Medicine • Diane Nugent -CIBD • Amit Soni- CIBD • Jason Zell- HemeOnc • SherifRezk- Pathology • Sheila Zhao- Pathology
Who do we interact with most often? • Lab Med/Pathology • Transfusion Med • Maternal-Fetal • ICU • Medicine • Surgery
Hematology IP/OP Rotation • Started July 1 • Dedicated fellow • Attendings: Kahlon and Claster • Residents and students welcome • Rounds on consults 5 days a week • Clinic at UCI Mon/Thurs pm • Clinic at CIBD either Wed pm or Friday am • Heme conference Tues 1 pm • Transfusion Medicine involvement- TBD • Monthly didactic presentation at the end of the rotation
Center for Inherited Blood Disorders • HTC- Hemophlia, VWD • Hemoglobinopathies • Thrombosis • Rare Bleeding Disorders- FXIII, PAI-1 inhibitor • Platelet disorders- genetic and acquired
Services/Team at CIBD • All pts seen by RN, MSW, PT, psychologist • Medical home • FQHC look alike • Member of community clinic consortium • Funding for uninsured pts • Navigators for covered Ca • Grants pending-CMS innovation grant, HRSA for SCD regional care • Dr Nugent/CIBD coordinating center for Western states Hemophilia region IX
In Progress • Involvement of Transfusion Medicine • Having more residents and students on the service • More formal didactic sessions with trainees presenting articles,talks
Metrics • Survey monkey • ASH site exam results- fellows • Numbers of students/residents who take rotation
Pretest • On a scale of 1-5( 1 being completely uncomfortable and needing a consult and 5 being very comfortable with the workup and don’t need additional help ) please rate your comfort level managing patients with the following diagnoses: • Microcytic anemia • Macrocytic anemia • thrombocytopenia • ITP • Sickle cell disease • HIT • Coagulopathicpt • Thrombosis • TTP • Pregnant pt w/clot • AIHA • Delayed tx reaction • Leukopenia